Portions of the proposed rules, including but not limited to the definition of these rules and the effect of the rules on Collective Medical’s ability to operate its business.; Monday, October 7, 2019; at 1:00 p.m.; Department of Health, 4042 Bald ...  

  •  

    DEPARTMENT OF HEALTH

    Prescription Drug Monitoring Program

    RULE NOS.:RULE TITLES:

    64K-1.001Patient Advisory Alerts and Reports

    64K-1.003Accessing Database

    64K-1.004Management and Operation of Database

    64K-1.005Privacy of Controlled Substance Prescription Dispensing Information

    64K-1.007Indicators of Controlled Substance Abuse

    64K-1.008Electronic Health Recordkeeping System Integration

    The Prescription Drug Monitoring Program announces a hearing to which all persons are invited.

    DATE AND TIME: Monday, October 7, 2019, 1:00 p.m.

    PLACE: Department of Health, 4042 Bald Cypress Way, Tallahassee, FL 32311

    GENERAL SUBJECT MATTER TO BE CONSIDERED: Portions of the proposed rules, including but not limited to the definition of these rules and the effect of the rules on Collective Medical’s ability to operate its business.

    A copy of the agenda may be obtained by contacting: Rebecca Poston, Program Manager, Prescription Drug Monitoring program, 4052 Bald Cypress Way, Bin #C-16, Tallahassee, Florida 32399 or Rebecca.Poston@FlHealth.gov.

    Pursuant to the provisions of the Americans with Disabilities Act, any person requiring special accommodations to participate in this workshop/meeting is asked to advise the agency at least 5 days before the workshop/meeting by contacting: Rebecca Poston, Program Manager, at the contact information shown above. If you are hearing or speech impaired, please contact the agency using the Florida Relay Service, 1(800)955-8771 (TDD) or 1(800)955-8770 (Voice).

Document Information

Hearing Meeting:
Department of Health, 4042 Bald Cypress Way, Tallahassee, FL 32311
Subject:
Portions of the proposed rules, including but not limited to the definition of these rules and the effect of the rules on Collective Medical’s ability to operate its business.
Meeting:
hearing
Contact:
Rebecca Poston, Program Manager, Prescription Drug Monitoring program, 4052 Bald Cypress Way, Bin #C-16, Tallahassee, Florida 32399 or Rebecca.Poston@FlHealth.gov.
Related Rules: (6)
64K-1.001. Patient Advisory Alerts and Reports
64K-1.003. Accessing Database
64K-1.004. Management and Operation of Database
64K-1.005. Privacy of Information
64K-1.007. Indicators of Controlled Substance Abuse
More ...